Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years
1997 ◽
Vol 103
(1)
◽
pp. 154
2019 ◽
Vol 126
(7)
◽
pp. 879-888
◽
2020 ◽
Vol 21
(14)
◽
pp. 1659-1665
1999 ◽
Vol 66
(4)
◽
pp. 541-544
◽
2004 ◽
Vol 62
(Issue 6, Supplement 4)
◽
pp. S12-S17
◽
Keyword(s):
2017 ◽
Vol 45
◽
pp. 33-38
◽
1990 ◽
Vol 53
(2)
◽
pp. 96-101
◽